CN104739723A

CN104739723A - Tightening eye cream

Info

Publication number: CN104739723A
Application number: CN201510120523.4A
Authority: CN
Inventors: 龚盛昭
Original assignee: Guangdong Industry Technical College
Current assignee: Guangdong Industry Technical College
Priority date: 2015-03-19
Filing date: 2015-03-19
Publication date: 2015-07-01

Abstract

The invention relates to a tightening eye cream which comprises the following raw materials: polysiloxane-11, cyclomethicone, butanediol, glycerinum, dicaprylyl carbonate, trimethylsilanolate silicate ester, phenyl trimethicone, polydimethylsiloxane, cyclopentasiloxane, arachidyl glucoside, glyceryl stearate, PEG-100 stearate, cetostearyl alcohol, acetyl tetrapeptide-5, a purslane extract, panthenol, vitamin E, a ginger root extract, bisabolol, phenoxyethanol, methylparaben, a crylic acid (ester)/C10-30 alkanol acrylic ester cross-linked polymer, propylparaben, aminomethyl propanol, coenzyme Q10, sodium hyaluronate, an essence and EDTA disodium. The tightening eye cream provided by the invention contains the efficient nutrients such as acetyl tetrapeptide-5, purslane extract, panthenol, vitamin E, a ginger root extract, bisabolol, coenzyme Q10 and sodium hyaluronate, is capable of improving the skin elasticity by promoting cell differentiation and collagen synthesis, is capable of promoting metabolism of a skin cutin layer so that the skin becomes relatively soft and smooth; the tightening eye cream is capable of effectively promoting skin regeneration to reach the effects of relieving winkles and tightening the skin; and meanwhile, the polysiloxane-11 has the efficacies of instantly smoothing fine wrinkles of eye skin and tightening the skin.

Description

One is compacted eye cream

Technical field

The present invention relates to cosmetic field, be specifically related to one and compact eye cream.

Background technology

It is generally acknowledged, wrinkle mainly produces by aging is lax, because epidermal tissue's drying is thinning, and the collagen protein of skin corium and elastic fibers supplement not enough and attenuate, and lose mesh-supported power.Skin follows the string, and suffers to extrude just no longer to restore afterwards, thus forms skin sagging, generation wrinkle.If the function of sebaceous gland declines, sebum secretion reduces, and sebum film is not easily formed, and cuticular moisture will easily run off, and makes skin become dry, to the eye of the number of times one day of blinking up to 10,000 times, more easily produces little microgroove.

Secondly, ultraviolet radiation meeting growth-promoting eye wrinkle-removing, the ultraviolet in sunlight is the catalyst that eye skin is aging, directly can cause the expansion of ocular angiogenesis, ossein and the impaired reduction of elastin fiber, can make skin quality significantly decline, accelerate ageing processes of skin, wrinkle is occurred ahead of time.

3rd, habitual expression can facilitate individual to form " expression " wrinkle, and during expression motion, muscle can shrink, and long term accumulation gets off, muscle tone enhancing, thus do express one's feelings time muscle and skin between can form fold, namely our said expression stricture of vagina.

Therefore nurse eye, effectively promote skin regeneration, reach and alleviate wrinkle, compact skin, smooths the new trend that canthus microgroove is exactly eye cosmetic exploitation instantly.

Summary of the invention

The invention provides one to compact eye cream, can smooth eye part skin microgroove instantaneously, compact skin around the eyes.

One is compacted eye cream, it is characterized in that being made up of the component of following percentage by weight: GRANSIL GCM-5 5.0%-27.0%, Cyclomethicone 2%-10%, butanediol 1%-6%, glycerol 1%-6%, dicaprylyl carbonate 1%-8%, trimethylsiloxysilicates 1.5-3%, phenyl trimethicone 0.5%-4%, polydimethylsiloxane 1.0%-2.0%, ring five polydimethylsiloxane 0.5%-1.0%, arachidic alcohol glucoside 1.5%-3.0%, glyceryl stearate 0.5%-1.0%, PEG-100 stearate 0.5%-1.0%, cetearyl alcohol 0.5%-1.5%, acetyl group tetrapeptide-5 0.5%-1.5%, Herba portulacae extract 0.05%-2.5%, pantothenylol 0.1%-1.5%, vitamin E 0.5%-1.5%, ginger-root extract 0.05%-0.30%, bisabolol 0.01%-0.5%, phenoxyethanol 0.1%-0.5%, methyl hydroxybenzoate 0.01%-0.25%, acrylic acid (ester) class/C10-30 alkylol acrylamide acid esters cross linked polymer 0.1%-0.25%, propylparaben 0.01%-0.15%, aminomethyl propanol 0.06%-0.15%, coenzyme Q10 0.01%-0.20%, hyaluronate sodium 0.01-0.30%, essence 0.01%-0.0.30%, EDETATE SODIUM 0.01%-0.1%, deionized water adds to 100%.

Preferably, one is compacted eye cream, it is characterized in that, be made up of the component of following percentage by weight: GRANSIL GCM-5 25.5%, Cyclomethicone 6%, butanediol 4%, glycerol 3%, dicaprylyl carbonate 3%, trimethylsiloxysilicates 2%, phenyl trimethicone 2%, polydimethylsiloxane 1.5%, ring five polydimethylsiloxane 0.8%, arachidic alcohol glucoside 2.0%, glyceryl stearate 0.75%, PEG-100 stearate 0.75%, cetearyl alcohol 1%, acetyl group tetrapeptide-5 1%, Herba portulacae extract 1%, pantothenylol 0.6%, vitamin E 1%, ginger-root extract 0.05%, bisabolol 0.3%, phenoxyethanol 0.3%, methyl hydroxybenzoate 0.20%, acrylic acid (ester) class/C10-30 alkylol acrylamide acid esters cross linked polymer 0.15%, propylparaben 0.10%, aminomethyl propanol 0.09%, coenzyme Q10 0.05%, hyaluronate sodium 0.05%, essence 0.05%, EDETATE SODIUM 0.02%, deionized water 42.74%.

Preferably, one is compacted eye cream, the percentage by weight of described component is: dicaprylyl carbonate 3.0%, phenyl trimethicone 2.0%, polydimethylsiloxane 1.5%, cetearyl alcohol 1.0%, arachidic alcohol glucoside 2.0%, glyceryl stearate 0.75%, PEG-100 stearate 0.75%, methyl hydroxybenzoate 0.2%, propylparaben 0.1%, coenzyme Q10 0.05%, GRANSIL GCM-5 25.0%, Cyclomethicone 6.50%, trimethylsiloxysilicates 2.0%, vitamin E 1.0, ring five polydimethylsiloxane 0.80%, acrylic acid (ester) class/C10-30 alkylol acrylamide acid esters cross linked polymer 0.15%, butanediol 4.0%, EDETATE SODIUM 0.02%, glycerol 3.0%, hyaluronate sodium 0.05%, pantothenylol 0.6%, aminomethyl propanol 0.09%, acetyl group tetrapeptide-5 1.0%, Herba portulacae extract 1.0%, ginger-root extract 0.05%, bisabolol 0.3%, phenoxyethanol 0.3%, essence 0.05%, deionized water 42.74%.

Beneficial effect: the eye cream that compacts of the present invention contains the efficient nutritional labeling such as acetyl group tetrapeptide-5, Herba portulacae extract, pantothenylol, vitamin E, ginger-root extract, bisabolol, coenzyme Q10, hyaluronate sodium, by promoting that cell differentiation and collage synthesis improve skin elastic; And the cuticular metabolism of skin can also be promoted, make skin become more a softer and smoother touch, and effectively promote skin regeneration, reach and alleviate wrinkle, the effect of the skin that compacts; Simultaneously GRANSIL GCM-5 has and smooths eye part skin microgroove instantaneously, and compact skin around the eyes.

Detailed description of the invention

Below by way of specific embodiment, the present invention is further illustrated, but these embodiments are just in order to illustrate, do not do any type of restriction to the present invention.

embodiment 1: one is compacted eye cream

Formula is shown in Table 1.

Table 1

The eye cream that compacts of one described in the present embodiment is prepared by following steps:

1, B phase is pre-mixed, is uniformly dispersed;

2, successively each for A phase component is added oil phase pot, stir and be warming up to 80-85 DEG C, melt evenly completely;

3, C phase is uniformly dispersed in advance, D phase is added aqueous phase pot successively simultaneously, add after stirring

C phase scattered in advance, is warming up to 80-85 DEG C, is uniformly dissolved suction emulsifying pot completely,

Stirring is warming up to 80-85 DEG C;

4, B scattered is in advance added in A phase, stirs and be warming up to 80-85 DEG C, melt all completely

After even, emulsifying pot evacuation (0.03MPa), utilizes negative pressure by the material in oil phase pot through filter

Net in slow suction emulsifying pot and carry out emulsifying, open homogenizing (3000rpm/min) simultaneously and stir,

Time with 15-20min, then open cycle water for cooling, and keep vacuum with froth breaking;

5, be cooled to 60 DEG C, add E phase, stir and homogenizing 3-5min;

6, be cooled to 45 DEG C, add F phase successively, stir, vacuumizing and defoaming;

7, continue to be cooled to 38 DEG C, discharging after the assay was approved.

embodiment 2: one is compacted eye cream

Formula is shown in Table 2.

Table 2

embodiment 3: one is compacted eye cream

Formula is shown in Table 3

Table 3

The eye cream that compacts of one described in embodiment 2, embodiment 3 is prepared by following steps:

1, B phase is pre-mixed, is uniformly dispersed;

3, C phase is uniformly dispersed in advance, D phase is added aqueous phase pot successively simultaneously, add after stirring and disperse in advance

Good C phase, is warming up to 80-85 DEG C, is uniformly dissolved suction emulsifying pot completely, stirs and be warming up to 80-85 DEG C;

4, B scattered is in advance added in A phase, stirs and be warming up to 80-85 DEG C, melt completely evenly, breast

Change pot evacuation (0.03MPa), utilize negative pressure by the material in oil phase pot through filter screen slow suction emulsifying pot

Inside carry out emulsifying, open homogenizing (3000rpm/min) simultaneously and stir, the time, with 15-20min, then opens

Circulating water cooling, and keep vacuum with froth breaking;

5, be cooled to 60 DEG C, add E phase, stir and homogenizing 3-5min;

7, continue to be cooled to 38 DEG C, discharging after the assay was approved.

the common eye cream of comparative example 1

Formula is shown in Table 4.

Table 4

Its preparation method is as follows:

1, B phase is pre-mixed, is uniformly dispersed;

3, C phase is added aqueous phase pot successively, stirs, be uniformly dissolved after be warming up to 80-85 DEG C, then take out

Enter emulsifying pot, stir and be warming up to 80-85 DEG C;

Circulating water cooling, and keep vacuum with froth breaking;

5, be cooled to 45 DEG C, add D phase, stir and homogenizing 3-5min, vacuumizing and defoaming;

6, continue to be cooled to 38 DEG C, discharging after the assay was approved.

experimental example 1 skin irritation test

With 60 women and 40 male for object, getting 0.03ml sample with syringe is placed in the coyote hole of speckle examination adhesive tape, longitudinally be affixed on the normal skin of left forearm by the speckle examination adhesive tape being equipped with sample from bottom immediately, light pressing room, to drive away air, and makes trier be uniformly distributed one by one simultaneously.Labelling is carried out, to observe in test position.Pasted skin once every 24 hours, open half an hour after paster, then check according to the term of CTFA guide (1981).Carrying out 6 patch experiments altogether, the 6th day after subsides skin terminates, in order to observe late response, having carried out additional inspection.Data then utilize last check result, compare.Identify with table 5 as standard is carried out.Substances is respectively compact eye cream and the common eye cream of comparative example of embodiment 1, and result is as shown in table 6.

Table 5 standard of perfection

Grade	Symbol	Standard of perfection
			0	-	Negative reaction: non-stimulated, without erythema
1	±	Suspicious reaction: slight erythema
			2	+	Weak positive reaction: erythema
3	++	Strong positive reaction: erythema, pimple, vesicle
			4	+++	Extremely strong positive reaction: serious edema, bulla

One kind, table 6 compacts the irritant test result of eye cream and common eye cream

Lagging number of times	Comparative example 1	Blank experiment	Embodiment 1
				1	0	0	0
2	0	0	0
				3	1 time ±	0	0
4	1 time ±	0	0
				5	1 time ±	0	0
6	1 time ±	0	0
				Terminate latter 6th day	1 time ±	0	0
Add up to	5 times ±	0	0

By this result of the test, can recognize that blank experiment is non-stimulated, the eye cream that compacts of embodiment 1 is non-stimulated to skin, and the irritant reaction of common eye cream to skin of comparative example still exists.Thus use compact after eye cream to human body without any allergy and discomfort, the present invention is relatively general, and eye cream product has safe and non-stimulating feature.

experimental example 2 tightening effect is tested

Choose the women in 40 eye part skins coarse 25-30 year, be divided equally into first, second two groups, often organize 20 people.Wherein, first group uses the eye cream that embodiment 1 is prepared; Second group uses common eye cream, and the every day of each use sooner or later once, and contrasts after 2 months:

1, comparing result:

First group: after using product, the eye part skin of 20 people has clear improvement at once, and coarse texture at once reduces or disappears

Lose, skin seems smooth instantaneously, compacts;

Second group: after using product, the eye part skin of 20 people is not improved substantially, and skin is still coarse, is just just coated with

Slightly water moisture feeling during upper product;

2, long-term comparing result:

First group: the eye part skin of 19 people has clear improvement, coarse texture reduces or disappears, and skin is moist.

Second group: the eye part skin of 6 people has clear improvement, separately has the eye part skin of 3 people slightly to improve, all the other people

Eye skin still coarse.

Through contrast test, can find out that the present invention has remarkable effect to eye part skin, can promote that eye skin regenerates, and reaches and alleviates wrinkle, the effect of the skin that compacts; Have simultaneously and smooth eye part skin microgroove instantaneously, compact skin around the eyes, makes skin moist, not chafe, is applicable to life-time service.

Claims

1. the eye cream that compacts, it is characterized in that, be made up of the component of following percentage by weight: GRANSIL GCM-5 5.0%-27.0%, Cyclomethicone 2%-10%, butanediol 1%-6%, glycerol 1%-6%, dicaprylyl carbonate 1%-8%, trimethylsiloxysilicates 1.5-3%, phenyl trimethicone 0.5%-4%, polydimethylsiloxane 1.0%-2.0%, ring five polydimethylsiloxane 0.5%-1.0%, arachidic alcohol glucoside 1.5%-3.0%, glyceryl stearate 0.5%-1.0%, PEG-100 stearate 0.5%-1.0%, cetearyl alcohol 0.5%-1.5%, acetyl group tetrapeptide-5 0.5%-1.5%, Herba portulacae extract 0.05%-2.5%, pantothenylol 0.1%-1.5%, vitamin E 0.5%-1.5%, ginger-root extract 0.05%-0.30%, bisabolol 0.01%-0.5%, phenoxyethanol 0.1%-0.5%, methyl hydroxybenzoate 0.01%-0.25%, acrylic acid (ester) class/C10-30 alkylol acrylamide acid esters cross linked polymer 0.1%-0.25%, propylparaben 0.01%-0.15%, aminomethyl propanol 0.06%-0.15%, coenzyme Q10 0.01%-0.20%, hyaluronate sodium 0.01-0.30%, essence 0.01%-0.0.30%, EDETATE SODIUM 0.01%-0.1%, deionized water adds to 100%.

2. the eye cream that compacts, it is characterized in that, be made up of the component of following percentage by weight: GRANSIL GCM-5 25.5%, Cyclomethicone 6%, butanediol 4%, glycerol 3%, dicaprylyl carbonate 3%, trimethylsiloxysilicates 2%, phenyl trimethicone 2%, polydimethylsiloxane 1.5%, ring five polydimethylsiloxane 0.8%, arachidic alcohol glucoside 2.0%, glyceryl stearate 0.75%, PEG-100 stearate 0.75%, cetearyl alcohol 1%, acetyl group tetrapeptide-5 1%, Herba portulacae extract 1%, pantothenylol 0.6%, vitamin E 1%, ginger-root extract 0.05%, bisabolol 0.3%, phenoxyethanol 0.3%, methyl hydroxybenzoate 0.20%, acrylic acid (ester) class/C10-30 alkylol acrylamide acid esters cross linked polymer 0.15%, propylparaben 0.10%, aminomethyl propanol 0.09%, coenzyme Q10 0.05%, hyaluronate sodium 0.05%, essence 0.05%, EDETATE SODIUM 0.02%, deionized water 42.74%.

3. the eye cream that compacts, it is characterized in that, be made up of the component of following percentage by weight: GRANSIL GCM-5 25.5%, Cyclomethicone 6%, butanediol 4%, glycerol 3%, dicaprylyl carbonate 3%, trimethylsiloxysilicates 2%, phenyl trimethicone 2%, polydimethylsiloxane 1.5%, ring five polydimethylsiloxane 0.8%, arachidic alcohol glucoside 2.0%, glyceryl stearate 0.75%, PEG-100 stearate 0.75%, cetearyl alcohol 1%, acetyl group tetrapeptide-5 1%, Herba portulacae extract 1%, pantothenylol 0.6%, vitamin E 1%, ginger-root extract 0.05%, bisabolol 0.3%, phenoxyethanol 0.3%, methyl hydroxybenzoate 0.20%, acrylic acid (ester) class/C10-30 alkylol acrylamide acid esters cross linked polymer 0.15%, propylparaben 0.10%, aminomethyl propanol 0.09%, coenzyme Q10 0.05%, hyaluronate sodium 0.05%, essence 0.05%, EDETATE SODIUM 0.02%, deionized water 42.74%.

4. preferred, one is compacted eye cream, the percentage by weight of described component is: dicaprylyl carbonate 3.0%, phenyl trimethicone 2.0%, polydimethylsiloxane 1.5%, cetearyl alcohol 1.0%, arachidic alcohol glucoside 2.0%, glyceryl stearate 0.75%, PEG-100 stearate 0.75%, methyl hydroxybenzoate 0.2%, propylparaben 0.1%, coenzyme Q10 0.05%, GRANSIL GCM-5 25.0%, Cyclomethicone 6.50%, trimethylsiloxysilicates 2.0%, vitamin E 1.0, ring five polydimethylsiloxane 0.80%, acrylic acid (ester) class/C10-30 alkylol acrylamide acid esters cross linked polymer 0.15%, butanediol 4.0%, EDETATE SODIUM 0.02%, glycerol 3.0%, hyaluronate sodium 0.05%, pantothenylol 0.6%, aminomethyl propanol 0.09%, acetyl group tetrapeptide-5 1.0%, Herba portulacae extract 1.0%, ginger-root extract 0.05%, bisabolol 0.3%, phenoxyethanol 0.3%, essence 0.05%, deionized water 42.74%.